Methylcobalamin vs Cyanocobalamin: Dose and Diagnosis Matter More Than Form

What are methylcobalamin and cyanocobalamin?

Both are vitamin B12. They share the same core, which contains cobalt, and differ in the small group attached to it.

• Methylcobalamin has a methyl group attached. It is one of the two forms cells use, which is why it is sold as "active" B12.
• Cyanocobalamin has a cyanide group attached. It is stable and cheap, and it has been used in several trials treating B12 deficiency with pills; the body removes the cyanide group and rebuilds the forms it needs.

For most people, either form works. The National Institutes of Health says supplement absorption has not been shown to differ by form, and cells rebuild both into the same working forms of B12. Both forms have adult treatment research, but the trials described here do not directly compare them.

What matters more than the form is the dose, and whether you have a diagnosed deficiency that needs a doctor's plan.

For B12’s role in the body, food sources, daily needs and deficiency testing, see our vitamin B12 guide.

Methylcobalamin and cyanocobalamin at a glance

The evidence matters more than “active” marketing

Absorption and use

Both forms use the same absorption route. Inside cells, the methyl or cyanide group is removed, and the cell rebuilds the two forms it needs—methylcobalamin and adenosylcobalamin—from the same core. Buying an “active” form does not bypass this processing. A 2015 review concluded that the working forms are not likely to be better than cyanocobalamin for preventing or treating deficiency.

A 1971 study compared four B12 forms, including methylcobalamin and cyanocobalamin, at small swallowed doses of 1, 5, and 25 mcg. No form came out on top consistently; the best one changed with the dose.

The deficiency trials

Both forms have adult treatment research. A small 1998 trial used 2 mg of oral cyanocobalamin daily and reported blood and neurologic improvement alongside an injection comparison. A 2018 trial after gastric bypass^[1] used 1 mg of oral methylcobalamin daily against hydroxocobalamin injections for six months; both restored serum B12. These different populations, routes and outcomes do not establish a winner between oral methylcobalamin and oral cyanocobalamin.

A 2005 trial in older people with low B12 found that oral doses of about 650–1,000 mcg a day produced most of the measured drop in methylmalonic acid, a blood marker that runs high when B12 is low. A 2021 review of medical records in 158 children under 3 found that blood B12 rose with methylcobalamin dissolved under the tongue, swallowed cyanocobalamin, and injected cyanocobalamin alike, but it was not a randomized trial.

The cyanide

The cyanide group makes up about 2 percent of cyanocobalamin's weight, so a 1,000 mcg tablet carries about 20 mcg of cyanide, calculated from the molecule's weight. The body removes the group as it processes B12. Calculating its weight alone does not show that a nutritional B12 dose causes cyanide toxicity. People with Leber hereditary optic neuropathy, a rare inherited eye disease, should avoid cyanocobalamin and let their doctor choose another form.

MTHFR

MTHFR is a gene that affects folate processing, and many people carry a common variant. Products often say people with this variant need "methylated" B12. That has not been shown: the methyl group on methylcobalamin is removed and rebuilt inside the cell like any other form, and no trial has shown better outcomes from methylcobalamin in people with the variant.

Read one label before choosing the form

• Micrograms of B12. The Daily Value is 2.4 mcg. A 1,000 mcg tablet is about 400 times that. The body absorbs only a small share of large doses: about 2 percent of 500 mcg (roughly 10 mcg) and about 1.3 percent of 1,000 mcg (roughly 13 mcg).
• 1 mg equals 1,000 mcg. Some labels list milligrams; the amount is the same.
• Bigger is not proven better. A 5,000 mcg methylcobalamin chewable is two and a half to five times the 1,000 to 2,000 mcg used in the treatment trials, with no trial showing an added benefit.
• "Active" or "bioactive." This describes the molecule, not proof that it works better.

Who should let a doctor choose the form?

• People with a diagnosed B12 deficiency, pernicious anemia (an autoimmune condition that blocks B12 absorption from the gut), or gut surgery that affects absorption. The dose, route (pill or injection), and follow-up tests need a plan; the trials that support pills used set doses and checked results.
• People with Leber hereditary optic neuropathy. Avoid cyanocobalamin.
• People with a cobalt allergy. Both forms contain cobalt, so a doctor should decide whether you need B12 and how to take it.

Rare acne-like eruptions have been reported with B12 treatment^[2], including oral use. The reports do not show that methylcobalamin avoids this reaction better than cyanocobalamin. Discuss a new eruption with the prescriber so they can address the reaction and continue treating the deficiency.

Can methylcobalamin help diabetic nerve symptoms?

Yes. A placebo-controlled trial in people with diabetes-related nerve damage who had taken the blood-sugar medicine metformin long term^[3] found improvements in pain and several nerve measures with 1,000 mcg/day methylcobalamin for a year. Some tests remained unchanged. It establishes a result for methylcobalamin in that setting, but the comparison was placebo, not cyanocobalamin. Our B12 guide gives the trial details and the newer dose comparison.

The bottom line

This comparison does not decide whether you need a B12 supplement. If you have already decided to use one and do not have a diagnosed deficiency, either form works; cyanocobalamin has the stronger adult treatment record, while methylcobalamin is a reasonable preference at a similar dose rather than a proven upgrade. Deficiency treatment needs its own dose and follow-up plan. For B12's roles in the body and the available forms, read our full vitamin B12 guide.